Search research articles
Contact Us
Filters
Showing results (571-580 of 637) with videos related to
Page
of 64
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
March 22, 2021
Reference Intervals for Brachial Artery Flow-Mediated Dilation and the Relation With Cardiovascular Risk Factors
Sophie M Holder, Rosa Maria Bruno, Daria A Shkredova, et al.
Schizophrenia Bulletin
|
March 4, 2023
Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants
Til Wykes, Dominic Stringer, Janette Boadu, et al.
Nature Biomedical Engineering
|
December 22, 2022
Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles
Ruyi Wang, Shijie Cao, Mohamed Elfatih H Bashir, et al.
Schizophrenia (Heidelberg, Germany)
|
September 30, 2023
Satisfaction with cognitive remediation therapy: its effects on implementation and outcomes using the cognitive remediation satisfaction scale
Joanne Evans, Rose Tinch-Taylor, Emese Csipke, et al.
Early Intervention in Psychiatry
|
October 5, 2022
Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study)
Brian O'Donoghue, Kelly Allott, Susy Harrigan, et al.
JAMA Neurology
|
February 24, 2016
Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease
Simon Mead, Matthew Burnell, Jessica Lowe, et al.
The Australian and New Zealand Journal of Psychiatry
|
August 26, 2025
Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO study
Monika Schlögelhofer, Ashleigh Lin, Connie Markulev, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
November 26, 2025
Exploring the interconnections between baseline symptoms in ultra-high risk youth who did and did not transition to psychosis over three years: A network analysis comparison
Gabriele Lo Buglio, Simon Hartmann, Tommaso Boldrini, et al.
Schizophrenia Research. Cognition
|
March 14, 2022
Digital technology for addressing cognitive impairment in recent-onset psychosis: A perspective
Imogen Bell, Roos M C A Pot-Kolder, Stephen J Wood, et al.
JAMA Psychiatry
|
November 29, 2016
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial
Patrick D McGorry, Barnaby Nelson, Connie Markulev, et al.
Page
of 64
Search research articles
Search
Showing results (571-580 of 637) with videos related to
Sort By:
Page
of 64
Hypertension (Dallas, Tex. : 1979)
|
March 22, 2021
Reference Intervals for Brachial Artery Flow-Mediated Dilation and the Relation With Cardiovascular Risk Factors
Sophie M Holder, Rosa Maria Bruno, Daria A Shkredova, et al.
Schizophrenia Bulletin
|
March 4, 2023
Cognitive Remediation Works But How Should We Provide It? An Adaptive Randomized Controlled Trial of Delivery Methods Using a Patient Nominated Recovery Outcome in First-Episode Participants
Til Wykes, Dominic Stringer, Janette Boadu, et al.
Nature Biomedical Engineering
|
December 22, 2022
Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles
Ruyi Wang, Shijie Cao, Mohamed Elfatih H Bashir, et al.
Schizophrenia (Heidelberg, Germany)
|
September 30, 2023
Satisfaction with cognitive remediation therapy: its effects on implementation and outcomes using the cognitive remediation satisfaction scale
Joanne Evans, Rose Tinch-Taylor, Emese Csipke, et al.
Early Intervention in Psychiatry
|
October 5, 2022
Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study)
Brian O'Donoghue, Kelly Allott, Susy Harrigan, et al.
JAMA Neurology
|
February 24, 2016
Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease
Simon Mead, Matthew Burnell, Jessica Lowe, et al.
The Australian and New Zealand Journal of Psychiatry
|
August 26, 2025
Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO study
Monika Schlögelhofer, Ashleigh Lin, Connie Markulev, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
November 26, 2025
Exploring the interconnections between baseline symptoms in ultra-high risk youth who did and did not transition to psychosis over three years: A network analysis comparison
Gabriele Lo Buglio, Simon Hartmann, Tommaso Boldrini, et al.
Schizophrenia Research. Cognition
|
March 14, 2022
Digital technology for addressing cognitive impairment in recent-onset psychosis: A perspective
Imogen Bell, Roos M C A Pot-Kolder, Stephen J Wood, et al.
JAMA Psychiatry
|
November 29, 2016
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial
Patrick D McGorry, Barnaby Nelson, Connie Markulev, et al.
Page
of 64